Real‐World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study

Real‐World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study

ABSTRACT Although drugs for osteoporosis have been demonstrated to be effective in reducing fracture risk in placebo‐controlled clinical trials, data on effectiveness in real‐world practice is limited. Data from the French national health insurance claims database (SNDS) were used to follow five coh...

Full description

Bibliographic Details
Main Authors:	Pauline Bosco‐Lévy, Karine Briot, Nadia Mehsen‐Cetre, James O'Kelly, Gaëlle Désaméricq, Abdelilah Abouelfath, Régis Lassalle, Angela Grelaud, Adeline Grolleau, Patrick Blin, Cécile Droz‐Perroteau
Format:	Article
Language:	English
Published:	Oxford University Press 2023-09-01
Series:	JBMR Plus
Subjects:	ANTIRESORPTIVE MEDICATIONS FRACTURE INCIDENCE HEALTHCARE DATABASE OSTEOPOROSIS
Online Access:	https://doi.org/10.1002/jbm4.10789

Similar Items

Osteoporosis: Current review
by: Alok Chandra Agrawal, et al.
Published: (2014-01-01)

Pharmacogenetics of Osteoporosis: A Pathway Analysis of the Genetic Influence on the Effects of Antiresorptive Drugs
by: Álvaro del Real, et al.
Published: (2022-04-01)

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
by: Leslie Spangler, et al.
Published: (2023-10-01)

The implicit reason of secondary osteoporosis: real clinical case
by: A. S. Shutova, et al.
Published: (2023-11-01)

Factors Associated With Adherence to Osteoporosis Medications Among Male Veterans
by: Nicole Sagalla, et al.
Published: (2021-08-01)

Analysis of Serum Proteome after Treatment of Osteoporosis with Anabolic or Antiresorptive Drugs
by: Alvaro del Real, et al.
Published: (2022-04-01)

Antiresorptive Versus Anabolic Therapy in Managing Osteoporosis in People with Type 1 and Type 2 Diabetes
by: Tatiane Vilaca, et al.
Published: (2023-11-01)

An observational study to assess back pain in patients with severe osteoporosis treated with teriparatide versus antiresorptives: An Indian subpopulation analysis
by: Harvinder Chhabra, et al.
Published: (2015-01-01)

Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study
by: Masanori Nakayama, et al.
Published: (2020-06-01)

Osteoporosis therapy initiation post-minimal trauma fracture
by: Mary Etty-Leal, et al.
Published: (2019-02-01)

Spontaneous medication-related osteonecrosis of the jaws in a 23-year-Old
by: Brenden J. Manley, et al.
Published: (2023-03-01)

Effectiveness of Different Treatment Modalities in Postmenopausal Women with Osteopenia and Osteoporosis
by: Berfu Demir, et al.
Published: (2009-12-01)

Anabolic and Antiresorptive Osteoporosis Treatment: Trends, Costs, and Sequence in a Commercially Insured Population, 2003–2021
by: Harsh Wadhwa, et al.
Published: (2023-10-01)

Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis
by: Junjie Lu, et al.
Published: (2022-06-01)

Recent Progresses in the Treatment of Osteoporosis
by: Shan-Shan Li, et al.
Published: (2021-07-01)

Treatment Consideration in Postmenopausal Osteoporosis Patients at Imminent Fracture Risk
by: Tai Pang Ip
Published: (2022-06-01)

Pharmacological Therapy of Osteoporosis: What’s New?
by: Iolascon G, et al.
Published: (2020-03-01)

Assessment and Treatment of Postmenopausal Osteoporosis: An Appraisal of International Guidelines
by: Sumapa Chaiamnuay
Published: (2022-06-01)

Organic Bone Matrix Component Type I and V Collagen Are Not Destructed in Bisphosphonate-Associated Osteonecrosis of the Jaws
by: Yahya Acil, et al.
Published: (2022-11-01)

Effectiveness of Antiresorptive Treatment on Formation of Nonvertebral Fracture in Old Age: A Retrospective Study
by: Hakan Tuna, et al.
Published: (2005-06-01)

Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study
by: Alma B. Pedersen, et al.
Published: (2023-06-01)

Target Values and Daytime Variation of Bone Turnover Markers in Monitoring Osteoporosis Treatment After Fractures
by: Tove T Borgen, et al.
Published: (2022-06-01)

Osteoporosis: a problem still faulty addressed by the Romanian healthcare system. Results of a questionnaire survey of people aged 40 years and over
by: Narcisa Jianu, et al.
Published: (2024-10-01)

Implications in dental treatment during the use of antiresorptive drugs - a literature review
by: Aleksandra Dziewulska, et al.
Published: (2024-10-01)

Bilateral atypical femoral fracture related to bisphosphonate therapy
by: Savić Aleksandra, et al.
Published: (2022-01-01)

The role of bone‐modifying agents in myeloma bone disease
by: Huifang Lu, et al.
Published: (2021-08-01)

The why and how of sequential and combination therapy in osteoporosis. A review of the current evidence
by: Manju Chandran
Published: (2022-12-01)

Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report
by: Daniela Cia Penoni, et al.
Published: (2023-05-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients
by: Salman Ali Alabdali, et al.
Published: (2024-12-01)

Skeletal responses to romosozumab after 12 months of denosumab
by: Michael R. McClung, et al.
Published: (2021-07-01)

Chronic Diffuse Sclerosing Osteomyelitis of the Mandible: The Use of Bisphosphonates as a Treatment for a Rare and Challenging Condition
by: Edgar Keller, et al.
Published: (2024-05-01)

In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review
by: Robert H. Guirguis, et al.
Published: (2023-06-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?
by: Jad G Sfeir, et al.
Published: (2021-10-01)

Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
by: Felicia Cosman, et al.
Published: (2021-11-01)

Bisphosphonates Preserve Bone Mineral Density and Suppress Bone Turnover Markers in Early Menopausal Women: A Systematic Review and Meta‐Analysis of Randomized Trials
by: Aria Ahadzadeh Ardebili, et al.
Published: (2023-06-01)

Changes in mandibular radiomorphometric indices in osteoporosis patients treated with denosumab: a retrospective case-control study
by: Katia Rupel, et al.
Published: (2024-01-01)

Alveolar bone density based on image density of intraoral radiography using artificial intelligence software: Cases of osteoporosis patients with antiresorptive medications administration before tooth extraction
by: Eizaburo Kobayashi, et al.
Published: (2022-01-01)

Incidence, prevalence, and predictors of osteoporotic fracture in adult lung transplant recipients
by: Elisabeth Ng, et al.
Published: (2025-02-01)